Eli Lilly Threatens Obesity Drug Copycat Makers After Shortage
Eli Lilly & Co. is targeting additional drug compounders and telehealth companies that make copycat versions of its weight ...
Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
New Atlas7d
Next-gen weight-loss drugs will be here within 12 months
Less than five years on from when Novo Nordisk's semaglutide drug received FDA approval for weight ... of delivering far superior weight loss compared to Lilly's Mounjaro, the company is ...
Live Mint on MSN11d
Mounjaro hits shelves in India: How Eli Lilly’s weight loss drug compares with Ozempic — price, side effects and more
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Will Weight Loss Drug, 'Mounjaro' Reduce Obesity In India? Doctor Reveals Side Effects Linked To This Treatment
Mounjaro, a GLP-1 receptor agonist, works by slowing digestion and suppressing appetite, leading to reduced caloric intake ...
Devdiscourse12d
Eli Lilly's Mounjaro Takes Lead in Indian Diabetes Drug Market
Eli Lilly expands its diabetes and weight-loss drug, Mounjaro, to India, outpacing Novo Nordisk. The drug is priced ...